Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bio-Reference Laboratories Company Profile (NASDAQ:BRLI)

Consensus Ratings for Bio-Reference Laboratories (NASDAQ:BRLI) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s)
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $36.90 (9.30% upside)

Analysts' Ratings History for Bio-Reference Laboratories (NASDAQ:BRLI)
Show:
DateFirmActionRatingPrice TargetActions
5/19/2015ZacksUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015ZacksDowngradeOutperform -> Neutral$36.90View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2014ZacksUpgradeNeutral -> Outperform$33.60View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014William BlairReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014Bank of AmericaDowngradeUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2014TheStreetDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2013Bank of AmericaReiterated RatingBuy$34.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/27/2013SidotiDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2013William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)